drugset / Trial / NCT00481728

Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.

NCT00481728

Phase 1 Completed 28 enrolled Viatris Inc.
RandomizedCrossoverDouble-blindOther

Summary

Measuring sympathetic skin response or heart rate variability can provide an objective biomarker of bladder sensation and its modulation by drug with potential to treat overactive bladder.

Timeline

Start
2007-06
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tolterodine Small molecule

Indications